Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento